Centennial Bank/Ar/ Novartis Ag Transaction History
Centennial Bank/Ar/
- $239 Billion
- Q2 2025
A detailed history of Centennial Bank/Ar/ transactions in Novartis Ag stock. As of the latest transaction made, Centennial Bank/Ar/ holds 500 shares of NVS stock, worth $59,655. This represents 0.03% of its overall portfolio holdings.
Number of Shares
500
Previous 520
3.85%
Holding current value
$59,655
Previous $58 Million
4.37%
% of portfolio
0.03%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding NVS
# of Institutions
1,550Shares Held
140MCall Options Held
1.69MPut Options Held
1.87M-
Dodge & Cox San Francisco, CA10.6MShares$1.27 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.24 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.08 Billion0.26% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$850 Million0.35% of portfolio
-
Morgan Stanley New York, NY7.06MShares$842 Million0.06% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $257B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...